Skip to content

Aeon Biopharma, Inc. (AEON) stock: revenue, earnings & dividend

Aeon Biopharma, Inc. (AEON, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener AEON ยท NYSE Pharma & Biotech US-CA

Key figures

Fiscal year
2025
Revenue
โ€“
Revenue growth
โ€“
Revenue growth 5y (p.a.)
โ€“
Net income
-39.22 m $
Net margin
โ€“
Operating margin
โ€“
Earnings per share (diluted)
-3.95 $
Dividend per share
โ€“
Payout ratio
โ€“
Consecutive dividend years
โ€“
Consecutive dividend raises
โ€“
Dividend growth 5y (p.a.)
โ€“
Total assets
5.56 m $
Equity
-55.03 m $
Equity ratio
-989.7 %
Return on equity
โ€“
Cash
3.01 m $
Operating cash flow
-17.31 m $
Free cash flow
-17.31 m $
Shares outstanding
84,121,648

History

Revenue by fiscal year

Net income by fiscal year

2021 8.2 m $
2022 -52.56 m $
2024 42 m $
2025 -39.22 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
2025โ€“-39.22 m $-3.95 $โ€“-17.31 m $
2024โ€“42 m $72.93 $โ€“-20.29 m $
2022โ€“-52.56 m $-0.38 $โ€“-35.58 m $
2021โ€“8.2 m $โ€“โ€“-1.49 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)